Carcinogenesis, Vol 19, 1409-1415, Copyright © 1998 by Oxford University Press
MK Smith, CS Trempus and SK Gilmour
Ornithine decarboxylase (ODC) is aberrantly regulated in tumor cells and
results in high basal levels of ODC and polyamines in many epithelial
tumors. To determine if elevated ODC/polyamine levels can co- operate with
a mutant Ha-ras gene in mouse skin tumorigenesis, double transgenic mice
were generated by breeding K6/ODC transgenic mice with TG.AC v-Ha-ras
transgenic mice. A K6 keratin promoter drives the ODC transgene in K6/ ODC
transgenic mice, which results in elevated ODC/ polyamine levels directed
to the outer root sheath cells of hair follicles. TG.AC transgenic mice
carry a v-Ha-ras transgene while still retaining two normal c-Ha-ras
alleles. Transgenic mice that possess only the K6/ODC or the v-Ha-ras
transgene did not develop tumors unless treated with either a carcinogen or
a tumor promoter, respectively. However, a high percentage of double
transgenic mice possessing both the K6/ODC and v-Ha-ras transgenes
developed spontaneous tumors. All tumors were well-differentiated
keratoacanthomas, some of which progressed to carcinomas within 2 months.
The development and the maintenance of these ODC/ras tumors was
ODC-dependent since alpha- difluoromethylornithine (DFMO), a specific ODC
inhibitor, prevented the formation and caused the regression of these
tumors. These findings indicate that ODC overexpression and an activated
Ha-ras are sufficient to produce a high rate of malignant transformation in
an animal model. The ODC/ras double transgenic mouse provides a simple in
vivo model without the use of chemical carcinogens or tumor promoters in
which to test downstream effectors that play a key role in mediating the
development of epithelial tumors resulting from the cooperation between ODC
and v-Ha-ras.
ARTICLES
Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin
Lankenau Medical Research Center, Wynnewood, PA 19096, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. F. Evageliou and M. D. Hogarty Disrupting Polyamine Homeostasis as a Therapeutic Strategy for Neuroblastoma Clin. Cancer Res., October 1, 2009; 15(19): 5956 - 5961. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Rounbehler, W. Li, M. A. Hall, C. Yang, M. Fallahi, and J. L. Cleveland Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma Cancer Res., January 15, 2009; 69(2): 547 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wei, K. DeFeo, C. S. Hayes, P. M. Woster, L. Mandik-Nayak, and S. K. Gilmour Elevated Ornithine Decarboxylase Levels Activate Ataxia Telangiectasia Mutated-DNA Damage Signaling in Normal Keratinocytes Cancer Res., April 1, 2008; 68(7): 2214 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Saunders and E. Verdin Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors. Mol. Cancer Ther., November 1, 2006; 5(11): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Hobbs, G. Wei, K. DeFeo, B. Paul, C. S. Hayes, and S. K. Gilmour Tip60 Protein Isoforms and Altered Function in Skin and Tumors that Overexpress Ornithine Decarboxylase Cancer Res., August 15, 2006; 66(16): 8116 - 8122. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Feith, S. Origanti, P. L. Shoop, S. Sass-Kuhn, and L. M. Shantz Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesis Carcinogenesis, May 1, 2006; 27(5): 1090 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Curtin, M. Hanausek, Z. Walaszek, R. Zoltaszek, J. E. Swauger, A. T. Mosberg, and T. J. Slaga Short-Term Biomarkers of Cigarette Smoke Condensate Tumor Promoting Potential in Mouse Skin Toxicol. Sci., January 1, 2006; 89(1): 66 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nie, W. Feng, R. Diaz, M. A. Gratton, K. J. Doyle, and E. N. Yamoah Functional Consequences of Polyamine Synthesis Inhibition by L-{alpha}-Difluoromethylornithine (DFMO): CELLULAR MECHANISMS FOR DFMO-MEDIATED OTOTOXICITY J. Biol. Chem., April 15, 2005; 280(15): 15097 - 15102. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, J. L. Cleveland, and T. G. O'Brien Haploinsufficiency for Odc Modifies Mouse Skin Tumor Susceptibility Cancer Res., February 15, 2005; 65(4): 1146 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Paul, C. S. Hayes, A. Kim, M. Athar, and S. K. Gilmour Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice Carcinogenesis, January 1, 2005; 26(1): 119 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Sistare, K. L. Thompson, R. Honchel, and J. DeGeorge Evaluation of the Tg.AC Transgenic Mouse Assay for Testing the Human Carcinogenic Potential of Pharmaceuticals--Practical Pointers, Mechanistic Clues, and New Questions International Journal of Toxicology, January 1, 2002; 21(1): 65 - 79. [Abstract] [PDF] |
||||
![]() |
C. A. Hobbs, B. A. Paul, and S. K. Gilmour Deregulation of Polyamine Biosynthesis Alters Intrinsic Histone Acetyltransferase and Deacetylase Activities in Murine Skin and Tumors Cancer Res., January 1, 2002; 62(1): 67 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Martin, C. Trempus, M. Saulnier, F. W. Kari, J.C. Barrett, and J. E. French Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice Carcinogenesis, September 1, 2001; 22(9): 1373 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ahmad, A. C. Gilliam, S. K. Katiyar, T. G. O'Brien, and H. Mukhtar A Definitive Role of Ornithine Decarboxylase in Photocarcinogenesis Am. J. Pathol., September 1, 2001; 159(3): 885 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Feith, L. M. Shantz, and A. E. Pegg Targeted Antizyme Expression in the Skin of Transgenic Mice Reduces Tumor Promoter Induction of Ornithine Decarboxylase and Decreases Sensitivity to Chemical Carcinogenesis Cancer Res., August 1, 2001; 61(16): 6073 - 6081. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lan, C. Trempus, and S. K. Gilmour Inhibition of Ornithine Decarboxylase (ODC) Decreases Tumor Vascularization and Reverses Spontaneous Tumors in ODC/Ras Transgenic Mice Cancer Res., October 1, 2000; 60(20): 5696 - 5703. [Abstract] [Full Text] |
||||
![]() |
M. A. Otieno and T. W. Kensler A Role for Protein Kinase C-{{delta}} in the Regulation of Ornithine Decarboxylase Expression by Oxidative Stress Cancer Res., August 1, 2000; 60(16): 4391 - 4396. [Abstract] [Full Text] |
||||
![]() |
S. K. Gilmour, M. Birchler, M. K. Smith, K. Rayca, and J. Mostochuk Effect of Elevated Levels of Ornithine Decarboxylase on Cell Cycle Progression in Skin Cell Growth Differ., November 1, 1999; 10(11): 739 - 748. [Abstract] [Full Text] |
||||
![]() |
Y. Wang, W. Devereux, T. M. Stewart, and R. A. Casero Jr. Cloning and Characterization of Human Polyamine-modulated Factor-1, a Transcriptional Cofactor That Regulates the Transcription of the Spermidine/Spermine N1-Acetyltransferase Gene J. Biol. Chem., July 30, 1999; 274(31): 22095 - 22101. [Abstract] [Full Text] [PDF] |
||||








